NEW YORK (TheStreet) --
Saul Centers (BFS) was downgraded to sell at TheStreet Ratings.
Allergan (NOK) was downgraded at Goldman Sachs. Valuation call, based on a $110 price target, Goldman said.
Big Lots (BIG) was downgraded to hold at TheStreet Ratings.CH Robinson (CHRW) was downgraded at Goldman Sachs to sell from neutral. $56 price target. Light truck names should lag the broader group, Goldman said. Facebook (FB) was upgraded at UBS to buy from neutral. Price target goes to $30. Current valuation is low and new monetization efforts are encouraging, UBS said. Forest Laboratories (FRX) was upgraded at Goldman Sachs to buy from neutral. $50 price target. See a higher potential for management to explore strategic options, Goldman said. Fulton Financial (FULT) was downgraded at Credit Suisse to underperform from neutral. $9.50 price target. Expect negative revisions to mortgage banking estimates, Credit Suisse said. (KMB) was upgraded at BMO Capital Markets to market perform from underperform. Valuation call, based on a $96 price target, BMO Capital Markets said. Medicines Company (MDCO) was downgraded at Oppenheimer to perform from outperform. New analyst believes the stock is fully valued, Oppenheimer said. Netgear (NTGR) was upgraded at Wedbush to outperform from neutral. $38 price target. Company has potential catalysts for the second half and 2014, Wedbush said. Questcor (QCOR) was downgraded at Bank of America/Merrill Lynch to neutral from buy. $51 price target. Acthar could face increased competition, BofA/Merrill said. (SO) was upgraded at Citigroup to buy from neutral. The GP rate case will be manageable, and Vogtle cost overruns do not present a structural issue, Citi said. SPX (SPW) was downgraded at Citigroup to sell from neutral. Price target is $68. There is significant second half earnings risk and valuation is elevated, Citigroup said. Total System (TSS) was upgraded to outperform at Wells Fargo. Company shows unanticipated FCF growth and trades at a cheap multiple, Wells Fargo said.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV